TOG
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Obstetrician & Gynaecologist 2006;8:1:26-31
doi: 10.1576/toag.8.1.026.27205
Copyright © 2006 by the Royal College of Obstetricians and Gynaecologists.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gupta, S.

Reviews

Obesity and female hormones

Sunanda Gupta, MFFP FRCOG

Consultant in Community Gynaecology, Waltham Forest PCT, Hurst Road Health Centre, Walthamstow, London E17 3BL, UK E-mail: sunanda.gupta{at}wf-pct.nhs.uk

This article reviews the impact of obesity on hormonal contraceptives and hormone replacement therapy (HRT) at the climacteric, with emphasis on efficacy and adverse effects in relation to arterial and venous thrombosis, myocardial infarction and stroke. The association, whether causal or otherwise, between obesity, weight gain, hormonal contraception and HRT is discussed.

Keywords efficacy / hormonal contraceptives / hormone replacement therapy / obesity / weight gain







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Royal College of Obstetricians and Gynaecologists.